Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMED
- Status
- COMPLETED
- Phase
- PHASE2
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Investigate the Contribution of Ipatasertib to Neoadjuvant Chemotherapy Plus Atezolizumab in TNBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
AMT-151 in Patients With Selected Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1
Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)
- Status
- RECRUITING
- Phase
- PHASE2
Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment
- Status
- TERMINATED
- Phase
- N/A
Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment
- Status
- RECRUITING
- Phase
- N/A
A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers
- Status
- RECRUITING
- Phase
- PHASE1
Tucidinostat and Metronomic Capecitabine for Metastatic Triple-negative Breast Cancer:a Multicenter,Open-label, Randomized Controlled, Phase II Clinical Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of XMT-1660 in Participants With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1